Diaceutics PLC (DIUXF)
OTC Markets OTCPK · USD · Healthcare · Health Information Services
$2.31 (+0.00%) as of
Key statistics
- Market cap
- 195.95M
- EPS (TTM)
- -0.0000
- Dividend yield
- 0.00%
- 52-week range
- 1.3672 – 2.5100
- Beta
- 0.77
- Revenue (TTM)
- 41.33M
- Profit margin
- -0.66%
- Volume
- 3.50k
About Diaceutics PLC
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, that enables potential therapy eligibility for patients within hours of a diagnostic event, enabling teams to act while treatment decisions are still pending; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers scientific and advisory services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Belfast, United Kingdom
- Employees
- 205
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.